Skip to content
Psych Dictionary

Matrix model

  • Therapy · Cognitive-behavioral
  • Limited or early evidence
  • Published October 19, 2026
  • 14 sources
  • 5 min read

In short

The Matrix model is a manualized 16-week intensive outpatient treatment for stimulant use disorders, developed at the Matrix Institute in Los Angeles during the 1980s, that combines relapse prevention and early recovery groups, education, social support, individual or family sessions and regular urine testing.
Related in this topic
On this page

Key facts

Tradition
Cognitive-behavioral
Developed by
Rawson, Obert, McCann and colleagues at the Matrix Institute on Addictions, Los Angeles
Origin
1980s, Los Angeles, for cocaine use; tested with methamphetamine use from the 1990s
Typical format
Manualized 16-week outpatient program, usually two to four sessions a week, mainly in groups, with optional individual or conjoint sessions and weekly urine testing
Most researched for
Methamphetamine dependence; Cocaine dependence; Methamphetamine use during methadone treatment (combined with contingency management)
Also known as
Matrix Model of intensive outpatient treatment; Matrix intensive outpatient program; Matrix treatment

State of the evidence

Limited or early evidence

In the largest randomized trial, 978 people with methamphetamine dependence at eight community clinics attended more sessions and had more drug-free urine samples during treatment with the Matrix model than with usual treatment, but the advantage was not present at discharge or six months after admission[1]. Earlier evaluations were uncontrolled or methodologically limited[2][3]. A 2020 systematic review counted it among effective behavioral treatments but found the strongest evidence for contingency management[4], and a network meta-analysis rated the evidence for a Matrix combination as very low in certainty[5].

Evidence labels summarise the research literature; they are not recommendations. How labels are assigned

The Matrix model is a manualized intensive outpatient treatment for people who use stimulants such as cocaine and methamphetamine. Over 16 weeks it combines relapse prevention groups, education groups, social support groups, individual counseling and urine and breath testing, delivered in a fixed structure[6]. Its developers describe it as directive but nonconfrontational, focused on current issues and on changing behavior[6].

The model is a package rather than a single technique. It is not contingency management, which rewards verified abstinence with incentives, although the two have been combined in trials[7]. Nor is it twelve-step facilitation, a treatment built around engagement with mutual-help groups. Its developers describe it as drawing several psychosocial interventions from treatment manuals published by the US National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism, and adding basic explanations of brain research for patients[8]. Later users of the model describe it as a cognitive-behavioral treatment that includes individual, group and family sessions[9].

Origins in the Los Angeles cocaine clinics

The model was developed during the 1980s at the Matrix Institute in Los Angeles, in response to heavy demand for treatment of cocaine use[2][6]. In the institute’s own account, it was built from components that research on substance use had supported and was revised as data on it accumulated[2]. The same group later applied it to methamphetamine use, reporting that people who used methamphetamine appeared to respond to it much as people who used cocaine did[6].

The early evaluations were reported by the developers. A pilot study compared the outpatient model with an inpatient hospital program and gave preliminary support for its clinical usefulness. An open trial found that publicly funded patients, who had fewer resources, were harder to engage and retain than privately funded ones. In a controlled trial, more and longer involvement in treatment went with better outcomes at one year, but the authors stated that methodological problems prevented the study from answering whether the treatment itself was effective[2]. An interim analysis of 146 participants in a demonstration project found the same dose–response pattern: longer treatment episodes and abstinence during treatment were associated with abstinence at six months[3]. Associations of this kind cannot separate the effect of treatment from the characteristics of the people who stay in it.

The 16-week program

Published descriptions specify the structure of the standardized program. In one clinic implementing it, the core 16 weeks comprised eight early recovery sessions, held twice a week during the first four weeks, and 32 relapse prevention sessions, held twice a week throughout, with optional weekly individual or conjoint sessions. Clients typically attended two to four sessions a week. A random urine drug screen was required at least weekly, and clients whose main substance was alcohol also took breath tests[9].

The early recovery groups are confined to the first month, whereas the relapse prevention groups run for the whole program and make up most of the sessions[9]. The developers’ own summary adds education and social support groups and individual counseling to these core groups[6]. The manual has been translated and adapted for people who use cocaine in Mexico and methamphetamine in Thailand[8], and since 2007 the model has been offered within primary health care in Cape Town, South Africa[10].

The Methamphetamine Treatment Project

The main test of the model was the Methamphetamine Treatment Project, funded by the US Center for Substance Abuse Treatment and described by its investigators as the largest randomized trial of treatment for methamphetamine dependence at the time. Between 1999 and 2001, 978 treatment-seeking people with methamphetamine dependence at eight community outpatient sites, six in California and one each in Montana and Hawaii, were randomly assigned to the 16-week Matrix model or to the usual treatment at each site[1].

During treatment the Matrix model did better on the reported measures of retention and drug use. Participants assigned to it attended more sessions, stayed in treatment longer, provided more methamphetamine-free urine samples and had longer periods of abstinence, in the sample as a whole and at most sites. At discharge and six months after admission, participants in both conditions had improved substantially from baseline, but the Matrix model’s advantage over usual treatment was no longer present[1]. A follow-up analysis of 420 participants found that the amount of methamphetamine used before treatment was the most consistent predictor of both in-treatment performance and later outcomes[11].

Adaptations and combinations

Later studies have mostly tested the model in new settings or alongside other treatments.

  • In Cape Town, a review of records from 2009 to 2014 found that 44% of 2,233 people screened began treatment. Of those who began, 45% attended at least four group sessions, 30% completed early recovery training and 13% completed the full 16 weeks, and about half of those who gave a urine sample at exit tested negative. Higher motivation at entry was associated with completion and a negative test[9].
  • In the same service, people whose main drug was methamphetamine were more likely than people whose main drug was an opioid to start and continue treatment, but the two groups did not differ in verified abstinence at exit[10].
  • In a sham-controlled trial with 60 men in Iran, adding active transcranial direct current stimulation to the Matrix model reduced craving more than the Matrix model alone or with sham stimulation, but relapse rates did not differ[12].
  • In a trial in 15 methadone clinics in Vietnam, people who continued to use methamphetamine after a first 12-week phase built on contingency management were re-randomized to 12 weeks of the Matrix model alone or the Matrix model with contingency management. The combination increased the percentage of methamphetamine-negative urine tests by 10.1 percentage points more than the Matrix model alone[7].

In a 2024 survey of US treatment facilities, 25% reported frequent use of the Matrix model together with contingency management, which the authors counted among combinations of recommended treatments for stimulant use disorder[13].

Limits of the evidence

The single large trial showed benefits during treatment that had faded by discharge and six months after admission[1]. Most other data come from the developers’ early uncontrolled or methodologically limited studies[2][3], from observational implementation studies[9][10] and from small trials in which the Matrix model is the background for another intervention[12]. A 2020 systematic review of nonpharmacological treatments for methamphetamine use listed the Matrix model among behavioral interventions that showed efficacy, but found the strongest evidence for contingency management[4]. A network meta-analysis of 72 randomized trials in amphetamine and methamphetamine use disorders found only very low-certainty evidence that methylphenidate combined with the Matrix model increased the proportion of negative urine samples, and no intervention with moderate- or high-certainty evidence of important benefit[5]. Across psychosocial treatments for stimulant use more broadly, a Cochrane review found that, compared directly with usual treatment, psychosocial interventions may improve retention but may not improve abstinence, and judged contingency management the most promising approach to add to usual treatment[14]. Which of the model’s components carry its in-treatment effect has not been tested.

Sources14

Numbered in order of first citation.

  1. 1.Rawson, R. A., Marinelli-Casey, P., Anglin, M. D., Dickow, A., Frazier, Y., Gallagher, C., Galloway, G. P., Herrell, J., Huber, A., McCann, M. J., Obert, J., Pennell, S., Reiber, C., Vandersloot, D., Zweben, J., & Methamphetamine Treatment Project Corporate Authors (2004). A multi‐site comparison of psychosocial approaches for the treatment of methamphetamine dependence. Addiction, 99(6), 708–717. https://doi.org/10.1111/j.1360-0443.2004.00707.x
  2. 2.Rawson, R. A., Shoptaw, S. J., Obert, J. L., McCann, M. J., Hasson, A. L., Marinelli-Casey, P. J., Brethen, P. R., & Ling, W. (1995). An intensive outpatient approach for cocaine abuse treatment. Journal of Substance Abuse Treatment, 12(2), 117–127. https://doi.org/10.1016/0740-5472(94)00080-b
  3. 3.Shoptaw, S., Rawson, R. A., McCann, M. J., & Obert, J. L. (1994). The Matrix model of outpatient stimulant abuse treatment: Evidence of efficacy. Journal of Addictive Diseases, 13(4), 129–141. https://doi.org/10.1300/j069v13n04_02
  4. 4.AshaRani, P. V., Hombali, A., Seow, E., Ong, W. J., Tan, J. H., & Subramaniam, M. (2020). Non-pharmacological interventions for methamphetamine use disorder: a systematic review. Drug and Alcohol Dependence, 212, 108060. https://doi.org/10.1016/j.drugalcdep.2020.108060
  5. 5.Khalili, M., Sadeghirad, B., Bach, P., Crabtree, A., Javadi, S., Sadeghi, E., Moradi, S., Mirzayeh Fashami, F., Nakhaeizadeh, M., Salehi, S., Sofi-Mahmudi, A., Nasiri, N., Mehmandoost, S., Moallef, S., Langeroodi, S. M. F., Moe, J., Lysyshyn, M., Werb, D., Buxton, J. A., & Karamouzian, M. (2025). Management of amphetamine and methamphetamine use disorders: A systematic review and network meta-analysis of randomized trials. International Journal of Mental Health and Addiction, 23(6), 4768–4786. https://doi.org/10.1007/s11469-024-01379-w
  6. 6.Obert, J. L., McCann, M. J., Marinelli-Casey, P., Weiner, A., Minsky, S., Brethen, P., & Rawson, R. (2000). The Matrix model of outpatient stimulant abuse treatment: History and description. Journal of Psychoactive Drugs, 32(2), 157–164. https://doi.org/10.1080/02791072.2000.10400224
  7. 7.Giang, L. M., Li, M. J., Trang, N. T., Diep, N. B., Dieu Thuy, D. T., Thuy, D. T., Hoe, H. D., Hai Van, H. T., Truc, T. T., Nguyen, H. H., Lai, N. L., Dan Linh, P. T., Tuong Vi, V. T., Reback, C. J., Leibowitz, A., Li, L., Lin, C., Van Dung, D., & Shoptaw, S. J. (2026). Interventions for methamphetamine use among people on methadone maintenance treatment in Vietnam: a sequential multiple assignment randomized trial (STAR-OM). The Lancet Regional Health - Southeast Asia, 48, 100773. https://doi.org/10.1016/j.lansea.2026.100773
  8. 8.Obert, J. L., London, E. D., & Rawson, R. A. (2002). Incorporating brain research findings into standard treatment: an example using the Matrix Model. Journal of Substance Abuse Treatment, 23(2), 107–113. https://doi.org/10.1016/s0740-5472(02)00266-0
  9. 9.Gouse, H., Magidson, J. F., Burnhams, W., Remmert, J. E., Myers, B., Joska, J. A., & Carrico, A. W. (2016). Implementation of cognitive-behavioral substance abuse treatment in sub-Saharan Africa: Treatment engagement and abstinence at treatment exit. PLOS ONE, 11(1), e0147900. https://doi.org/10.1371/journal.pone.0147900
  10. 10.Magidson, J. F., Gouse, H., Burnhams, W., Wu, C. Y., Myers, B., Joska, J. A., & Carrico, A. W. (2017). Beyond methamphetamine: Documenting the implementation of the Matrix model of substance use treatment for opioid users in a South African setting. Addictive Behaviors, 66, 132–137. https://doi.org/10.1016/j.addbeh.2016.11.014
  11. 11.Hillhouse, M. P., Marinelli-Casey, P., Gonzales, R., Ang, A., Rawson, R. A., & Methamphetamine Treatment Project Corporate Authors (2007). Predicting in‐treatment performance and post‐treatment outcomes in methamphetamine users. Addiction, 102(s1), 84–95. https://doi.org/10.1111/j.1360-0443.2007.01768.x
  12. 12.Fayaz Feyzi, Y., Vahed, N., Sadeghamal Nikraftar, N., & Arezoomandan, R. (2022). Synergistic effect of combined transcranial direct current stimulation and Matrix ‎Model on the reduction of methamphetamine craving and improvement of cognitive ‎functioning: a randomized sham-controlled study. The American Journal of Drug and Alcohol Abuse, 48(3), 311–320. https://doi.org/10.1080/00952990.2021.2015771
  13. 13.Frost, M. C., Coughlin, L. N., & Stewart, M. T. (2026). Provision of recommended treatment for stimulant use disorder in United States substance use treatment facilities. International Journal of Drug Policy, 155, 105428. https://doi.org/10.1016/j.drugpo.2026.105428
  14. 14.Minozzi, S., Saulle, R., De Crescenzo, F., & Amato, L. (2016). Psychosocial interventions for psychostimulant misuse. Cochrane Database of Systematic Reviews, 2016(9). https://doi.org/10.1002/14651858.CD011866.pub2

Further reading

  • Obert, J. L., McCann, M. J., Marinelli-Casey, P., Weiner, A., Minsky, S., Brethen, P., & Rawson, R. (2000). The Matrix model of outpatient stimulant abuse treatment: History and description. Journal of Psychoactive Drugs, 32(2), 157–164. https://doi.org/10.1080/02791072.2000.10400224
  • Rawson, R. A., Marinelli-Casey, P., Anglin, M. D., Dickow, A., Frazier, Y., Gallagher, C., Galloway, G. P., Herrell, J., Huber, A., McCann, M. J., Obert, J., Pennell, S., Reiber, C., Vandersloot, D., Zweben, J., & Methamphetamine Treatment Project Corporate Authors (2004). A multi‐site comparison of psychosocial approaches for the treatment of methamphetamine dependence. Addiction, 99(6), 708–717. https://doi.org/10.1111/j.1360-0443.2004.00707.x

Cite this entry

  • APA 7

    Psych Dictionary. (2026, October 19). Matrix model. In Psych Dictionary. https://www.psychdictionary.com/therapies/matrix-model

  • MLA 9

    “Matrix Model.” Psych Dictionary, 19 Oct. 2026, www.psychdictionary.com/therapies/matrix-model.

Written by Editorial team. First published October 19, 2026. Editorial standards

Educational reference material. Nothing on this site is a diagnosis, a treatment recommendation or a substitute for care from a qualified clinician.